Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210. Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212. Viewpoint Sep 2016 The Limits of Informed Consent for an Overwhelmed Patient: Clinicians’ Role in Protecting Patients and Preventing Overwhelm Johan Bester, MBChB, MPhil, Cristie M. Cole, JD, and Eric Kodish, MD Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity. AMA J Ethics. 2016;18(9):869-886. doi: 10.1001/journalofethics.2016.18.9.peer2-1609. In the Literature Apr 2005 Self-Regulation and the Relationship of Physicians with the Pharmaceutical Industry Justin M. Thomas Virtual Mentor. 2005;7(4):288-293. doi: 10.1001/virtualmentor.2005.7.4.jdsc1-0504. Medical Education Aug 2006 Pharmaceutical Support of Dermatology Residency Electives: Slippery Slope or Synergy? Alfred T. Lane, MD Virtual Mentor. 2006;8(8):509-511. doi: 10.1001/virtualmentor.2006.8.8.medu1-0608. Case and Commentary Aug 2005 Finding the (Right) Time: Physician-to-Drug Rep Communication Michael E. Roloff, PhD and Rachel Malis, MA Virtual Mentor. 2005;7(8):554-558. doi: 10.1001/virtualmentor.2005.7.8.ccas5-0508. Case and Commentary Nov 2006 Distributing Drug Samples in a Free Clinic: A Personal or Policy Decision? Amanda J. Redig Virtual Mentor. 2006;8(11):729-734. doi: 10.1001/virtualmentor.2006.8.11.conl1-0611. Viewpoint Nov 1999 The Value of Industry Gifts to Physicians Audiey Kao, MD, PhD Virtual Mentor. 1999;1(3):21-22. doi: 10.1001/virtualmentor.1999.1.3.dykn1-9911. Case and Commentary Feb 2013 Quality Improvement of Economic Profiling Marguerite Huff Virtual Mentor. 2013;125-130. doi: 10.1001/virtualmentor.2013.15.2.bndr2-1302. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210.
Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212.
Viewpoint Sep 2016 The Limits of Informed Consent for an Overwhelmed Patient: Clinicians’ Role in Protecting Patients and Preventing Overwhelm Johan Bester, MBChB, MPhil, Cristie M. Cole, JD, and Eric Kodish, MD Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity. AMA J Ethics. 2016;18(9):869-886. doi: 10.1001/journalofethics.2016.18.9.peer2-1609.
In the Literature Apr 2005 Self-Regulation and the Relationship of Physicians with the Pharmaceutical Industry Justin M. Thomas Virtual Mentor. 2005;7(4):288-293. doi: 10.1001/virtualmentor.2005.7.4.jdsc1-0504.
Medical Education Aug 2006 Pharmaceutical Support of Dermatology Residency Electives: Slippery Slope or Synergy? Alfred T. Lane, MD Virtual Mentor. 2006;8(8):509-511. doi: 10.1001/virtualmentor.2006.8.8.medu1-0608.
Case and Commentary Aug 2005 Finding the (Right) Time: Physician-to-Drug Rep Communication Michael E. Roloff, PhD and Rachel Malis, MA Virtual Mentor. 2005;7(8):554-558. doi: 10.1001/virtualmentor.2005.7.8.ccas5-0508.
Case and Commentary Nov 2006 Distributing Drug Samples in a Free Clinic: A Personal or Policy Decision? Amanda J. Redig Virtual Mentor. 2006;8(11):729-734. doi: 10.1001/virtualmentor.2006.8.11.conl1-0611.
Viewpoint Nov 1999 The Value of Industry Gifts to Physicians Audiey Kao, MD, PhD Virtual Mentor. 1999;1(3):21-22. doi: 10.1001/virtualmentor.1999.1.3.dykn1-9911.
Case and Commentary Feb 2013 Quality Improvement of Economic Profiling Marguerite Huff Virtual Mentor. 2013;125-130. doi: 10.1001/virtualmentor.2013.15.2.bndr2-1302.